Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.66 |
| ▸ | ACHE | P22303 | 12/20 | 0.58 |
| ▸ | NAAA | Q02083 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | FAAH | O00519 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11627977 | 0.92 | ALDH1A1 (0.58) | EPHX1ACHETSHR | |
| SCHEMBL5936326 | 0.90 | EPHX1 (0.73) | EPHX1ACHENAAATSHRFAAH | |
| SCHEMBL5936297 | 0.90 | EPHX1 (0.73) | EPHX1ACHENAAATSHRFAAH | |
| SCHEMBL5936318 | 0.90 | EPHX1 (0.73) | EPHX1ACHENAAATSHRFAAH | |
| SCHEMBL20597667 | 0.90 | EPHX1 (0.73) | EPHX1ACHENAAATSHRFAAH | |
| SCHEMBL5138408 | 0.87 | EPHX1 (0.69) | EPHX1ACHENAAAFAAH | |
| SCHEMBL14765424 | 0.85 | EPHX1 (0.61) | EPHX1ACHENAAATSHRFAAH | |
| SCHEMBL9459327 | 0.84 | EPHX1 (0.66) | EPHX1ACHENAAATSHRFAAH | |
| SCHEMBL9459137 | 0.84 | EPHX1 (0.66) | EPHX1ACHENAAATSHRFAAH | |
| SCHEMBL9459205 | 0.84 | EPHX1 (0.66) | EPHX1ACHENAAATSHRFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8742164-B2 | Method for producing toluenedicarbamate, method for producing toluenediisocyanate, and toluenedicarbamate | MITSUI CHEMICALS, INC. (JP) | 2014-06-03 | — | — | US | disclosed |
| US-20130109881-A1 | METHOD FOR PRODUCING TOLUENEDICARBAMATE, METHOD FOR PRODUCING TOLUENEDIISOCYANATE, AND TOLUENEDICARBAMATE | MITSUI CHEMICALS, INC. | 2013-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130109881-A1 | METHOD FOR PRODUCING TOLUENEDICARBAMATE, METHOD FOR PRODUCING TOLUENEDIISOCYANATE, AND TOLUENEDICARBAMATE | CPS1, TST, ALKBH3 | EPHX1 1851/4885ACHE 219/4885NAAA 85/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.